Name:
Dr William Redfern PhD FRSB DSP FBPhS
Organisation:
Certara UK Limited
Year elected:
2012
Primary professional setting:
Industry
Will Redfern is Vice President, Quantitative Systems Toxicology and Safety (QSTS) at Certara UK. He is an experienced safety pharmacologist and was previously Target Organ Expert for CNS Preclinical Safety within AstraZeneca. Received a BSc (Hons; 1st class) in pharmacology (Sunderland), PhD (Manchester), followed by a post-doc at the University of Birmingham, before a career in the pharmaceutical industry at Syntex, Quintiles and AstraZeneca. Will is also a Fellow of the Royal Society of Biology and an Honorary Senior Lecturer at the University of Manchester. He received the 2014 Distinguished Service Award from the Safety Pharmacology Society (SPS) and was SPS President during 2017.